Compound ID | 178
BC-9529
Class: Pleuromutilin
| Spectrum of activity: | Gram-positive & Gram-negative |
| Target Pathogen: | Active against methicillin-resistant and -susceptible Staphylococcus aureus, Streptococcus pneumoniae, Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae |
| Propensity to select resistant mutants: | Yes |
| Institute where first reported: | Nabriva Therapeutics, Austria |
| Year first mentioned: | 2010 |
| Development status: | Experimental |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.